SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: December 2, 2003
Date of earliest event reported: December 2, 2003
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware |
1-3619 |
13-5315170 |
(State or other Jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer |
235 East 42nd Street |
10017 |
(Address of principal executive offices)
Registrant's telephone number, including area code:
(212) 573-2323
Item 5. Other Events and Regulation FD Disclosure
On December 2, 2003, Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.) agreed to amend the Rights Agreement that they had entered into on October 6, 1997 (the "Agreement") to change the Final Expiration Date, as defined in the Agreement, to December 31, 2003. A copy of Amendment No. 1 to the Agreement is included as Exhibit 99 to this report and is incorporated herein by reference.
Item 7(c). |
Exhibits |
||
Exhibit 99 |
- |
Amendment No. 1 dated December 2,2003, to the Rights Agreement dated October 6, 1997 between Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.) |
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC. |
|
By: /s/Margaret M. Foran |
Dated: December 2, 2003
EXHIBIT INDEX
Exhibit No. |
Description |
99 |
Amendment No. 1 dated December 2, 2003, to the Rights Agreement dated October 6, 1997 between Pfizer Inc. and Mellon Investor Services LLC (successor to ChaseMellon Shareholder Services L.L.C.) |